| Sheila Yafai Bolour, Md Inc | |
|
150 N Robertson Blvd Ste 222 Beverly Hills CA 90211-2144 | |
| (310) 279-4649 | |
| Not Available |
| Full Name | Sheila Yafai Bolour, Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 150 N Robertson Blvd Ste 222, Beverly Hills, California |
| Authorized Official Name and Position | Sheila Bolour (PRESIDENT) |
| Authorized Official Contact | 3107803959 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Yafai Bolour, Md Inc Po Box 17923 Beverly Hills CA 90209-3923 Ph: (310) 780-3959 | Sheila Yafai Bolour, Md Inc 150 N Robertson Blvd Ste 222 Beverly Hills CA 90211-2144 Ph: (310) 279-4649 |
| NPI Number | 1639210313 |
|---|---|
| Provider Enumeration Date | 02/08/2007 |
| Last Update Date | 08/22/2020 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639210313 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | A75332 (California) | Primary |
News Archive
The United States Patent and Trademark Office (USPTO) has granted and issued Advaxis, Inc. (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, patent 7,588,930 "Compositions and Methods for Enhancing Immunogenicity of Antigens." This patent expands the Company's intellectual property portfolio to cover another family of adjuvant proteins based upon the Lm protein Act-A.
Following stem cell therapy, an adult patient experienced a new and previously unrecognized complication, which required removal of one of the kidneys, according to a case report appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The report suggests that stem cell therapy may cause patients to develop blood vessel and bone marrow masses, the long term effects of which are unknown.
PAREXEL International Corporation, a leading global biopharmaceutical services provider, today introduced IMPACT Express Clinical Trial Management System (CTMS).
Janssen R&D Ireland announced today it has signed a license agreement with PATH for the early development of the human immunodeficiency virus type 1 medicine rilpivirine in a long-acting injection (depot formulation) as potential pre-exposure prophylaxis against HIV infection.
› Verified 7 days ago
Treatmedngo Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8950 W Olympic Blvd Ste 103&104, Beverly Hills, CA 90211 Phone: 310-274-8080 | |
Refael Medical, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8200 Wilshire Blvd, Beverly Hills, CA 90211 Phone: 310-879-7167 Fax: 310-933-5688 | |
Michael D. Borookhim, M.d., Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9301 Wilshire Blvd, Suite 602, Beverly Hills, CA 90210 Phone: 310-288-0881 | |
Ultrasound Specialists Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9001 Wilshire Blvd, Suite 106, Beverly Hills, CA 90211 Phone: 310-273-8885 | |
Kaiser Permanente Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 204 S Arnaz Dr Apt 3, Beverly Hills, CA 90211 Phone: 213-215-5142 | |
Nancy P. Rahnama, M.d., A.p.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 421 N Rodeo Dr, Penthouse Number 1, Beverly Hills, CA 90210 Phone: 310-299-7373 Fax: 310-432-6647 | |
Laurence Seigler, M.d. Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 435 N Bedford Dr, Suite 308, Beverly Hills, CA 90210 Phone: 310-274-6158 Fax: 310-274-5709 |